• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'small cell lung carcinoma mesh'

Nagysejtes neuroendocrin carcinoma – a kórisme és a kezelés nehézségei

crine carcinoma of the lung. Adjuvant chemo- therapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neu- roendocrine

Protected

N/A

7
0
0
2022
VELUCT, a long non-coding RNA with an important cellular function despite low abundance

In non-small-cell lung carcinoma, the anti-sense transcript of the tumor suppressor in lung cancer 1 (TSLC1) RP11-713B9.1 was shown to be downregulated, and its functions as

Protected

N/A

3
0
0
2022
SEMMELWEIS EGYETEM DOKTORI ISKOLA Ph.D. értekezések 2403. KRENCZ ILDIKÓ

(2015) Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer,

Protected

N/A

138
0
0
2022
Ruthenium-Nitrosyl Complexes with Glycine, L-Alanine, L-Valine, L-Proline, D- Proline, L-Serine, L-Threonine and L-Tyrosine: Synthesis, X-ray Diffraction Structures, Spectroscopic and Electrochemical Properties and Antiproliferative Activity Anna Rathgeb,

Ruthenium and osmium analogs showed a striking difference in antiproliferative activity in three human cancer cell lines A549 nonsmall cell lung carcinoma, CH1 ovarian carcinoma

Protected

N/A

32
0
0
2022
by Silent Robots withMinimal Visibility Range

VCM – Invariants • There is at most one Leader > After the Leader gets stuck, the Leadership is transferred • Followers only follow their predecessor > Predecessor is either in a

Protected

N/A

53
0
0
2024
Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer

COPD has been reported as an additive burden and risk factor for developing lung cancer, mainly squamous cell carcinoma, especially in smokers [152].. In a study of 136 lung

Protected

N/A

20
0
0
2022
A Gorlin–Goltz-szindróma genetikai aspektusai

Rövidítések BCC = basal cell carcinoma basalsejtes carcinoma; GLI = gliomaasszociált protein; NBCCS = nevoid basal cell carcinoma syndrome naevoid basalsejtes carcinoma

Protected

N/A

6
0
0
2022
Detection of single alpha-helices in large protein sequence sets usinghardware acceleration

Interestingly, the percentage of arginine residues within positively charged ones defined as 100*N R (N R +N K ) (where N R represents the number of arginine and N K the number

Protected

N/A

23
0
0
2022
Számítógép az információszerzésben. Egy nagyvállalat tapasztalatai megtekintése

„idegen" terminálon kezdte meg az online szakirodalom- keresést, a Dialóg rendszer adatbázisainak használatával.. Az online irodalomkeresés jellemzői és értékelésük 1982

Protected

N/A

3
0
0
2022
Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free- Radical Scavenging

Following this, compounds 4 and 5 were also tested on a diverse panel of cancer cell lines, including MCF-7, HeLa, and SiHa, and several lung carcinoma cell lines, such as

Protected

N/A

12
0
0
2022
ARTICLE IN PRESS

mAb, Monoclonal antibody; MCF-7, Michigan Cancer Foundation-7 breast-cancer cell line; MDA-MB-231, Breast-cancer cell line; NSCLC, Non-small cell lung cancer; OEC- M1, Human

Protected

N/A

8
0
0
2022
25th International Symposium on Analytical and Environmental Problems

The noncovalent interaction between the Amyloid beta (Aβ) protein and a native complex mixture of gangliosides extracted and purified from normal adult human

Protected

N/A

1
0
0
2022
Protein Expression Differences Between Lung Adenocarcinoma and Squamous Cell Carcinoma with Brain Metastasis

Increased β-catenin, E-cadherin and decreased caspase-9 expression in primary SCC, and decreased CD44v6 expression in brain metastatic SCC tissues showed a significant correlation

Protected

N/A

5
0
0
2022
Introduction ClinicopathologicalFindingson28CaseswithXP11.2RenalCellCarcinoma

Yang B, Duan H, Cao W et al (2019) Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining:

Protected

N/A

11
0
0
2022
Rebiopszia és ismételt gefitinibkezeléssel elért remisszió tüdőrákban

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to

Protected

N/A

5
0
0
2022
Journal of Clinical Neuroscience

We base this hypothesis on the simultaneous presence of lung squamous cell carcinoma, characteristic symptoms of NMOSD and anti-AQP-4 antibodies in both the serum and CSF of

Protected

N/A

4
0
0
2022
Is surgery still the best management option for early stage NSCLC?

Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small- cell lung cancer. Interact Cardiovasc Thorac Surg

Protected

N/A

5
0
0
2022
Áron Kristóf Ghimessy

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. Vascular

Protected

N/A

174
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!